Association between arsenic exposure from drinking water and hematuria: results from the Health Effects of Arsenic Longitudinal Study.

[1]  L. Moore,et al.  Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile. , 2013, American journal of epidemiology.

[2]  S. Jacobsen,et al.  Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. , 2013, Mayo Clinic proceedings.

[3]  L. Moore,et al.  Drinking Water Arsenic in Northern Chile: High Cancer Risks 40 Years after Exposure Cessation , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Habibul Ahsan,et al.  The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem , 2013, Environmental health perspectives.

[5]  Scott D. Miller,et al.  Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. , 2012, The Journal of urology.

[6]  S. Shariat,et al.  Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer , 2012, World Journal of Urology.

[7]  Tyler R. McClintock,et al.  Arsenic exposure in Latin America: biomarkers, risk assessments and related health effects. , 2012, The Science of the total environment.

[8]  Y. Hsueh,et al.  Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area. , 2011, The Journal of urology.

[9]  Mengling Liu,et al.  Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. , 2011, International journal of epidemiology.

[10]  Mengling Liu,et al.  Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study , 2011, BMJ : British Medical Journal.

[11]  S. Jacobsen,et al.  Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. , 2011, The Journal of urology.

[12]  V. Zoumpourlis,et al.  Environmental factors and genetic susceptibility promote urinary bladder cancer. , 2010, Toxicology letters.

[13]  M. Bates,et al.  Kidney Cancer Mortality: Fifty-year Latency Patterns Related to Arsenic Exposure , 2010, Epidemiology.

[14]  Y. Hsueh,et al.  Urinary arsenic species and CKD in a Taiwanese population: a case-control study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Chien-Jen Chen,et al.  Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality. , 2009, Toxicology and applied pharmacology.

[16]  S. Vollset,et al.  Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated , 2008 .

[17]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[18]  M. Berglund,et al.  Urinary arsenic concentration adjustment factors and malnutrition. , 2008, Environmental research.

[19]  Alexander van Geen,et al.  Can information alone change behavior? Response to arsenic contamination of groundwater in Bangladesh , 2007 .

[20]  M. Bates,et al.  Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. , 2007, Journal of the National Cancer Institute.

[21]  F. Jasmine,et al.  Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh , 2007, Cancer Epidemiology Biomarkers & Prevention.

[22]  Takeo Kato,et al.  Clinical utility of trace proteinuria for microalbuminuria screening in the general population , 2007, Clinical and Experimental Nephrology.

[23]  F. Parvez,et al.  Reduction in Urinary Arsenic Levels in Response to Arsenic Mitigation Efforts in Araihazar, Bangladesh , 2007, Environmental health perspectives.

[24]  L. Cameron,et al.  Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis , 2007, Environmental health : a global access science source.

[25]  F. Parvez,et al.  Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. , 2006, American journal of epidemiology.

[26]  F. Parvez,et al.  Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. , 2006, Toxicology.

[27]  Zhongqi Cheng,et al.  Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. , 2006, American journal of epidemiology.

[28]  F. Parvez,et al.  Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation , 2006, Journal of Exposure Science and Environmental Epidemiology.

[29]  F. Parvez,et al.  Prevalence of Arsenic Exposure from Drinking Water and Awareness of Its Health Risks in a Bangladeshi Population: Results from a Large Population-Based Study , 2005, Environmental health perspectives.

[30]  L. Appel,et al.  Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. , 2005, Archives of internal medicine.

[31]  Xinhua Liu,et al.  Urinary Creatinine and Arsenic Metabolism , 2005, Environmental health perspectives.

[32]  K. Ahmed,et al.  Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. , 2005, Environmental science & technology.

[33]  Chun-Yuh Yang,et al.  Decreasing Trend in Renal Disease Mortality after Cessation from Arsenic Exposure in a Previous Arseniasis-Endemic Area in Southwestern Taiwan , 2005, Journal of toxicology and environmental health. Part A.

[34]  Y. Hsueh,et al.  Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. , 2004, JAMA.

[35]  D. Brooks,et al.  Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. , 2004, Toxicology and applied pharmacology.

[36]  F. Parvez,et al.  Validity of a food-frequency questionnaire for a large prospective cohort study in Bangladesh , 2004, British Journal of Nutrition.

[37]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[38]  Qing‐Yu He,et al.  A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. , 2004, The Biochemical journal.

[39]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[40]  M. Luster,et al.  Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. , 2003, Environmental health perspectives.

[41]  Fritz H. Frimmel,et al.  Arsenic — a Review. Part II: Oxidation of Arsenic and its Removal in Water Treatment , 2003 .

[42]  R. Cohen,et al.  Clinical practice. Microscopic hematuria. , 2003, The New England journal of medicine.

[43]  Roelof Versteeg,et al.  Spatial variability of arsenic in 6000 tube wells in a 25 km2 area of Bangladesh , 2003 .

[44]  Louis W. Chang,et al.  Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. , 2003, Environmental health perspectives.

[45]  Y. Hsueh,et al.  Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. , 2003, Toxicology letters.

[46]  Yu-Mei Hsueh,et al.  Epidemiologic evidence of diabetogenic effect of arsenic. , 2002, Toxicology letters.

[47]  J. Jeng,et al.  Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis , 2002, Circulation.

[48]  P. Carroll,et al.  Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. , 2001, Urology.

[49]  L. Ryan,et al.  Risk of internal cancers from arsenic in drinking water. , 2000, Environmental health perspectives.

[50]  A. Auvinen,et al.  Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. , 1999, Environmental health perspectives.

[51]  D. R. Lewis,et al.  Drinking water arsenic in Utah: A cohort mortality study. , 1999, Environmental health perspectives.

[52]  A H Smith,et al.  Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. , 1998, International journal of epidemiology.

[53]  C. Chen,et al.  Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. , 1997, Stroke.

[54]  M. Marre,et al.  Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. , 1997, Clinical nephrology.

[55]  T. Tai,et al.  Lipid Profile and Peripheral Vascular Disease in Arseniasis-Hyperendemic Villages in Taiwan , 1997, Angiology.

[56]  C. Chen,et al.  Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[57]  A H Smith,et al.  Case-control study of bladder cancer and arsenic in drinking water. , 1995, American journal of epidemiology.

[58]  T. Moyer,et al.  Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. , 1991, Clinical chemistry.

[59]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[60]  S. You,et al.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. , 1986, British Journal of Cancer.

[61]  C. J. Chen,et al.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. , 1985, Cancer research.

[62]  G. Pershagen,et al.  [Health effects of arsenic]. , 1984, Lakartidningen.

[63]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[64]  J. A. Roberson,et al.  Some drinking-water disinfectants and contaminants, including arsenic. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[65]  Andrew Gelman,et al.  Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. , 2002, Bulletin of the World Health Organization.

[66]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[67]  J. Harman.  Letter: Realistic goals for smoking and health. , 1974, Lancet.

[68]  C Slot,et al.  Plasma creatinine determination. A new and specific Jaffe reaction method. , 1965, Scandinavian journal of clinical and laboratory investigation.